Trial Site Detail

 

Drug:
BEZ235 + MEK162
Trial:
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Princess Margaret Hospital

610 University Ave     
Toronto , ON M5G 2M9
Canada

 

Principal Investigator:
Philippe Bedard, MD
Contact:
Philippe Bedard, MD +1-4616-946-4534 philippe.bedard@uhn.on.ca
Activation Status of this Site:
Not yet activated
Notes about this Site:
Princess Margaret Hospital Website:
http://www.uhn.ca/index.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.